Healius Ltd (HLS) - Total Assets

Latest as of December 2025: AU$1.77 Billion AUD ≈ $1.25 Billion USD

Based on the latest financial reports, Healius Ltd (HLS) holds total assets worth AU$1.77 Billion AUD (≈ $1.25 Billion USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Healius Ltd shareholders equity for net asset value and shareholders' equity analysis.

Healius Ltd - Total Assets Trend (1998–2025)

This chart illustrates how Healius Ltd's total assets have evolved over time, based on quarterly financial data.

Healius Ltd - Asset Composition Analysis

Current Asset Composition (June 2025)

Healius Ltd's total assets of AU$1.77 Billion consist of 14.2% current assets and 85.8% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 3.2%
Accounts Receivable AU$144.90 Million 8.2%
Inventory AU$29.80 Million 1.7%
Property, Plant & Equipment AU$938.50 Million 52.8%
Intangible Assets AU$56.60 Million 3.2%
Goodwill AU$430.00 Million 24.2%

Asset Composition Trend (1998–2025)

This chart illustrates how Healius Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Healius Ltd.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Healius Ltd's current assets represent 14.2% of total assets in 2025, an increase from 11.6% in 1998.
  • Cash Position: Cash and equivalents constituted 3.2% of total assets in 2025, down from 7.2% in 1998.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, a decrease from 130.0% in 1998.
  • Asset Diversification: The largest asset category is property, plant & equipment at 52.8% of total assets.

Healius Ltd Competitors by Total Assets

Key competitors of Healius Ltd based on total assets are shown below.

Company Country Total Assets
Dr. Lal Path Labs Ltd.
NSE:LALPATHLAB
India Rs31.46 Billion
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
China CN¥9.20 Billion
RHYTHM Biosciences Ltd
AU:RHY
Australia AU$3.10 Million
Check-Cap Ltd.
NASDAQ:MBAI
USA $7.49 Million
Sonic Healthcare Ltd
AU:SHL
Australia AU$17.03 Billion
Integral Diagnostics Ltd
AU:IDX
Australia AU$1.43 Billion
Australian Clinical Labs Ltd
AU:ACL
Australia AU$562.50 Million
Monash Ivf Group Ltd
AU:MVF
Australia AU$510.21 Million

Healius Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 0.58 1.29 0.47
Quick Ratio 0.50 1.25 0.42
Cash Ratio 0.00 0.00 0.00
Working Capital AU$-186.70 Million AU$233.80 Million AU$-328.20 Million

Healius Ltd - Advanced Valuation Insights

This section examines the relationship between Healius Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.69
Latest Market Cap to Assets Ratio 0.10
Asset Growth Rate (YoY) -40.4%
Total Assets AU$1.78 Billion
Market Capitalization $179.83 Million USD

Valuation Analysis

Below Book Valuation: The market values Healius Ltd's assets below their book value (0.10x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: Healius Ltd's assets decreased by 40.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for Healius Ltd (1998–2025)

The table below shows the annual total assets of Healius Ltd from 1998 to 2025.

Year Total Assets Change
2025-06-30 AU$1.78 Billion
≈ $1.26 Billion
-40.43%
2024-06-30 AU$2.98 Billion
≈ $2.11 Billion
-18.35%
2023-06-30 AU$3.65 Billion
≈ $2.58 Billion
-11.69%
2022-06-30 AU$4.14 Billion
≈ $2.93 Billion
+9.38%
2021-06-30 AU$3.78 Billion
≈ $2.68 Billion
-17.57%
2020-06-30 AU$4.59 Billion
≈ $3.25 Billion
+36.85%
2019-06-30 AU$3.35 Billion
≈ $2.37 Billion
+7.24%
2018-06-30 AU$3.13 Billion
≈ $2.21 Billion
+0.39%
2017-06-30 AU$3.11 Billion
≈ $2.20 Billion
-14.08%
2016-06-30 AU$3.62 Billion
≈ $2.56 Billion
-7.49%
2015-06-30 AU$3.92 Billion
≈ $2.77 Billion
+4.70%
2014-06-30 AU$3.74 Billion
≈ $2.65 Billion
-6.09%
2013-06-30 AU$3.98 Billion
≈ $2.82 Billion
+3.18%
2012-06-30 AU$3.86 Billion
≈ $2.73 Billion
+0.95%
2011-06-30 AU$3.83 Billion
≈ $2.71 Billion
+3.50%
2010-06-30 AU$3.70 Billion
≈ $2.62 Billion
-2.18%
2009-06-30 AU$3.78 Billion
≈ $2.67 Billion
-21.25%
2008-06-30 AU$4.80 Billion
≈ $3.40 Billion
+691.14%
2007-06-30 AU$606.50 Million
≈ $429.14 Million
+11.40%
2006-06-30 AU$544.42 Million
≈ $385.21 Million
+21.55%
2005-06-30 AU$447.90 Million
≈ $316.92 Million
+48.12%
2004-06-30 AU$302.39 Million
≈ $213.96 Million
+3.44%
2003-06-30 AU$292.33 Million
≈ $206.84 Million
+3.17%
2002-06-30 AU$283.35 Million
≈ $200.49 Million
+28.35%
2001-06-30 AU$220.78 Million
≈ $156.21 Million
+36.07%
2000-06-30 AU$162.25 Million
≈ $114.80 Million
+88.86%
1999-06-30 AU$85.91 Million
≈ $60.79 Million
+113.35%
1998-06-30 AU$40.27 Million
≈ $28.49 Million
--

About Healius Ltd

AU:HLS Australia Diagnostics & Research
Market Cap
$179.83 Million
AU$254.15 Million AUD
Market Cap Rank
#17068 Global
#490 in Australia
Share Price
AU$0.35
Change (1 day)
+0.00%
52-Week Range
AU$0.35 - AU$1.04
All Time High
AU$4.91
About

Healius Limited provides medical laboratory and pathology services in Australia. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics Pathology, QML Pathology, TML Pathology, Abbott Pathology, IQ Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories and patie… Read more